The expression of C-myb in human metastatic melanoma cell lines and specimens

Anticancer Research

Volumn 18, Issue 2 A, 1998, Pages 1129-1135

  Walker, Michael J ^a,d   Silliman, Elizabeth ^a,b   Dayton, Mark A ^c   Lang, James C ^a  

^a OHIO STATE UNIVERSITY   (United States)

^b OHIO STATE UNIVERSITY   (United States)

^c LA   (United States)

^d Division of Surgical Oncology   (United States)

Author keywords

Antisense therapy; c myb; Melanoma; Oncogene; Tumor suppressor genes

Indexed keywords

COMPLEMENTARY DNA;

ARTICLE; CANCER CELL CULTURE; CELL PROLIFERATION; CELL STRAIN K 562; CONTROLLED STUDY; GENE EXPRESSION; HUMAN; HUMAN CELL; MELANOMA CELL; METASTASIS; NORTHERN BLOTTING; ONCOGENE C MYB; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

EID: 0031866145     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (37)

1. Balch CM, Houghton A and Peters L: Cutaneous Melanoma. In: DeVita VT, Hellman S, Rosenberg SA (eds.), Cancer Principles and Practice of Oncology, 4th edition, pp. 1612-1678. Philadelphia: J.B.Lippincott, 1993.
2. Millikin D, Meese E, Vogelstein B, Witowski C, Trent J: Loss of heterozygosity for loci in the long arm of chromosome 6 in human malignant melanoma. Cancer Res 51: 5449-5453, 1991.
3. Linnenbach AJ, Huebner K, Reddy EP, Herlyn M, Parmiter AH, Nowell PC, Koprowski H: Structural alteration in the MYB protooncogene and deletion within the gene encoding alpha type protein kinase-C in human melanoma cell lines. Proc Natl Acad Sei USA 85: 74-78,1988.
4. Trent JM, Stanbridge EJ, McBride HL, Meese EU, Casey G, Araujo DE, Witkowsi CM, Nagle RB: Tumorigenicity in human melanoma cell lines controlled by introduction of human chromosome 6. Science 247: 568-571, 1990.
5. Hijiya N, Zhang J, Ratajczak MZ, Kant JA, DeRiel K Herlyn M, Zon G, Gewirtz AM: Biologic and therapeutic significance of MYB expression in human melanoma Proc Natl Acad Sci USA 91: 4499-4503, 1994.
6. Feucht KA, Walker MJ, Das Gupta TK, Beattie CW: Effect of 17B-estradiol on the growth of estrogen receptor-positive human melanoma in vitro and athymic mice. Cancer Res 48: 7093-7101, 1988.
7. Rauth S, Green A, Bratescu L, DasGupta TK Chromosome abnormalities in metastatic melanoma. In Vitro Cell Dev Biol 30A: 79-84, 1994.
8. Majello B, Kenyon LC, Dalla-Favera R: Human c-myb protooncogene: Nucleotide sequence of cDNA and organization of the genomic locus. Proc Natl Acad Sei USA 83: 9636-9640, 1986.
9. Introna M, Luchetti M, Castellano M, Arsura M, Golay J: The myb oncogene family of transcription factors: potent regulators of hematopoietic cell proliferation and differentiation. Sem CancerBiol 5: 113-124, 1994.
10. Lane KB, Zoia O, Davidson JM: Semidry electrophoretic transfer of RNA to membranes. BioTechniques 12: 340, 1992.
11. Ausubel FM, Brent R, Kingston RE, Moore DD, Smith JA, Seidman JG and Strohl K (eds.): Analysis of RNA by Northern Hybridization. In: Current Protocols in Molecular Biology, pp. 4.91-4.95. New York: Wiley Interscience and Greene Publishing, 1987.
12. Wahl GM, Ong E, Meinkoth J, Franco R and Barinaga M: Northern (RNA) Transfer onto S&S Nytran Nylon Membranes. In: Transfer and Immobilization of Nucleic Acids to S&S Solid Supports, pp. 26-27. Keene, New Hampshire, Schleicher and Schuell, 1987.
13. Ramsay RG, Thompson MA, Hayman JA, Reid G, Gonda TJ, Whitehead RH: Myb expression is higher in malignant human colonie carcinoma and premalignant adenomatous polyps than in normal mucosa. Cell Growth and Differentiation 3: 723-730, 1992.
14. Melani C, Rivoltini L, Parmiani G, Calabretta B, Colombo MP: Inhibition of proliferation by c-myb antisense oligonucleotides in colon adenocarcinoma cell lines that express c-myb. Cancer Res 51: 2897-2901, 1991.
15. Krchnak VI, Maly A, Flegel M: Solid-phase synthesis of a nonadecapeptide coded for by the c-myb oncogene. Int J Peptide Protein Res 31: 239-244, 1988.
16. Fumagalli S, Doneda L, Nomura N, Larizza L: Expression of the c-ski protooncogene in human melanoma cell lines. Mel Res 3: 23-27, 1993.
17. Husain Z, Fitzgerald GB, Wick MM: Comparison of cellular protooncogene activation and transformation-related activity of human melanocytes and metastatic melanoma. J Invest Dermatol 95: 571-575, 1990.
18. Slamon DS, deKernion JB, Verma IM, Cline MS: Expression of cellular oncogenes in human malignancies. Science (Washington, DC) 224: 256-261, 1984.
19. Calabretta B, Sims RB, Valtieri M, Caracciolo D, Szczylik C, Venturelli D, Beran M, Gewirtz AM: Normal and leukemic hematopoietic cells manifest differential sensitivity to inhibitory effects of c-myb antisense oligodeoxynucleotides: an in vitro study with relevance to bone marrow purging. Proc Natl Acad Sci USA 88: 4534-4538, 1991.
20. Ratajczak MZ, Kant JA, Luger SM, Hijiya N, Zhang J, Zon G, Gewirtz AM: In vivo treatment of human leukemia in a scid mouse model with c-myb antisense oligodeoxynucleotides. Proc Natl Acad Sci USA 89: 11823-11827, 1992.
21. Alitalo K, Winquist R, Linn CC, de La Chapelle A, Schwab M, Bishop JM. Aberrant expression of an amplified c-myb oncogene in two cell lines from a colon carcinoma Proc Natl Acad Sci USA 81: 4534-4538, 1984.
22. Trainer DL, Kline T, McCabe FL, Faucettte LF, Field J, Chaikin M, Anzano M, Rieman D, Hoffstein S, Li DJ, Gennaro, Buscarino C, Lynch M, Poste G, Drieg R: Biological characterization and oncogene expression in human colorectal carcinoma cell lines. Int J Cancer 41: 287-296, 1988.
23. Griffin CA, Baylin SB: Expression of the c-myb oncogene in human small cell lung carcinoma. Cancer Res 45: 272-275, 1985.
24. Janssen JWG, Vernole P, de Boer PAJ, Oosterhuis JW, Collard JG: Sublocalization of c-myb to 6q21-23 by in situ hybridization and c-myb expression in human teratocarcinoma with 6q rearrangements. Cytogenet Cell Genet 41: 129-135, 1986.
25. Thiele CJ, McKeon C, Triche TJ, Ross RA, Reynolds CP, Israel MA: Differential protooncogene expression characterizes histopathologically indistinguishable tumors of the peripheral nervous system. J Clin Invest 80: 804-811, 1987.
26. Weston K, Bishop JM: Transcriptional activation by the v-myb oncogene and its cellular progenitor c-myb. Cell 58: 85-93, 1989.
27. Luscher B, Eisenman RN: New light on myc and myb. Part II myb. Gene Dev 4: 2235-2241, 1990.
28. Ku DH, Wen S-C, Englehard A, Nicolaides NC, Lipson KE, Marino TA, Calbretta B: C-myb transactivates cdc2 expression via myb binding sites in the 5' flanking region of the human cdc2 gene. J Biol Chem 268: 2255-2259, 1993.
29. Gewirtz AM, Anfossi G, Venturelli D, Valpreda S, Sims R, Calabretta B: G1/S transition in normal human T-lymphocytes requires the nuclear protein encoded by c-myb. Science (Washington. DC) 245: 180-183, 1989.
30. Reiss K, Ferber A, Travali S, Porcu P, Phillips PD, Baserga R: The protooncogene c-myb increase the expression of insulin-like growth factor 1 and insulin-like growth factor 1 receptor messenger RNAs by a transcriptional mechanism. Cancer Res 51: 5997-6000, 1991.
31. Guerin M, Sheng ZM, Andrieu N, Riou G: Strong association between c-myb and oestrogen receptor expression in human breast cancer. Oncogene 5: 131-135, 1990.
32. Gudas JM, Klein RC, Oka M, Cowan KH: Posttranscriptional regulation of the c-myb protooncogene in estrogen receptor positive breast cancer cells. Clin Can Res 1: 235-243, 1995.
33. Kastan MB, Slamon DJ, Civin Cl: Expression of the protooncogene c-myb in nornal human hematopoietic cells. Blood 73: 1444-1451, 1989.
34. Thiele CJ, Cohen PS, Israel MA: Regulation of c-myb expression in human neuroblastoma cells during retinoic acid-induced differentiation. Mol Cell Biol 8: 1677-1688, 1988.
35. Anfossi, G, Gewirtz AM, Calabretta B: An oligmer complementary to c-myb encoded mRNA inhibits proliferation of human myeloid leukemia cell lines. Proc Natl Acad Sci USA 86: 3379 3383, 1989
36. Reintgen DS, Paull DE, Seigler HF, et al: Sex related survival differences in instances of melanoma. SG&O 159: 367-372, 1984.
37. Shaw HM, McGovern VJ, Milton GW, et al. Histologic features of tumors and the female supenority in survival from malignant melanoma. Cancer 45: 1604-1608, 1980.